Suminori Kono Selected Research

Glucose Intolerance

6/2013	Coffee consumption, serum γ-glutamyltransferase, and glucose tolerance status in middle-aged Japanese men.
1/2013	Effects of pravastatin and atorvastatin on HDL cholesterol and glucose metabolism in patients with dyslipidemia and glucose intolerance: the PRAT study.
6/2008	A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
7/2006	Relation of alcohol use and smoking to glucose tolerance status in Japanese men.
5/2006	Dietary patterns and glucose tolerance abnormalities in Japanese men.
1/2003	Glucose intolerance and serum aminotransferase activities in Japanese men.
12/2002	Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suminori Kono Research Topics

Disease

27	Colorectal Neoplasms (Colorectal Cancer) 07/2015 - 01/2002
15	Carcinogenesis 05/2014 - 11/2002
13	Adenoma (Adenomas) 07/2013 - 11/2002
12	Type 2 Diabetes Mellitus (MODY) 04/2020 - 12/2002
7	Colonic Neoplasms (Colon Cancer) 01/2015 - 12/2004
7	Glucose Intolerance 06/2013 - 12/2002
7	Neoplasms (Cancer) 08/2012 - 08/2002
6	Diabetes Mellitus 05/2017 - 01/2003
6	Inflammation (Inflammations) 02/2012 - 04/2007
6	Obesity 06/2010 - 01/2003
5	Myocardial Infarction 02/2011 - 01/2002
4	Rectal Neoplasms (Rectal Cancer) 01/2015 - 12/2004
4	Hypertension (High Blood Pressure) 02/2012 - 05/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2010 - 10/2005
4	Coronary Disease (Coronary Heart Disease) 11/2010 - 06/2003
3	Hypercholesterolemia 01/2012 - 05/2004
2	Overweight 01/2012 - 11/2002
2	Osteoporosis 04/2010 - 09/2009
2	Insulin Resistance 06/2008 - 11/2006
2	Abdominal Obesity 04/2008 - 10/2005
2	Hyperinsulinism (Hyperinsulinemia) 10/2005 - 12/2002
2	Cerebral Infarction 01/2005 - 06/2003
1	Cognitive Dysfunction 03/2017
1	Alzheimer Disease (Alzheimer's Disease) 03/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Polyps 01/2014
1	Atherosclerosis 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Carotid Artery Diseases 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2013

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 04/2020 - 11/2002
8	CalciumIBA 01/2015 - 07/2005
8	EnzymesIBA 07/2013 - 12/2004
7	LipidsIBA 04/2020 - 06/2003
7	Coffee FDA Link 06/2013 - 01/2010
7	HDL CholesterolIBA 01/2013 - 05/2004
7	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013 - 02/2003
6	CholesterolIBA 01/2012 - 06/2003
5	C-Reactive ProteinIBA 02/2012 - 04/2007
5	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2005 - 02/2003
4	TeaIBA 05/2017 - 04/2010
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2014 - 06/2006
3	Triglycerides (Triacylglycerol)IBA 01/2017 - 10/2005
3	LDL CholesterolIBA 01/2017 - 06/2008
3	Vitamin D FDA LinkGeneric 01/2015 - 10/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 01/2005
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2013 - 04/2007
3	IsoflavonesIBA 02/2013 - 01/2002
3	Atorvastatin (Lipitor)FDA Link 01/2013 - 06/2006
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2013 - 04/2007
3	Biomarkers (Surrogate Marker)IBA 02/2012 - 04/2009
3	BilirubinIBA 02/2011 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 11/2004
2	Ezetimibe (Zetia)FDA Link 01/2017 - 01/2012
2	Biological ProductsIBA 07/2015 - 10/2005
2	Dietary CalciumIBA 01/2015 - 01/2013
2	pitavastatin (itavastatin)FDA Link 01/2014 - 06/2008
2	8-hydroxyguanineIBA 01/2014 - 07/2010
2	CarcinogensIBA 07/2013 - 01/2009
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2013 - 06/2010
2	oxidized low density lipoproteinIBA 01/2013 - 06/2008
2	Thymidylate SynthaseIBA 01/2013 - 10/2012
2	CarbonIBA 01/2013 - 10/2012
2	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 01/2013 - 10/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2012 - 01/2003
2	Oxidoreductases (Dehydrogenase)IBA 10/2012 - 12/2004
2	AntioxidantsIBA 08/2012 - 04/2010
2	Caffeine (No Doz)FDA LinkGeneric 01/2012 - 05/2010
2	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2011 - 08/2007
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2010 - 01/2003
2	Alanine Transaminase (SGPT)IBA 04/2010 - 01/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2010 - 06/2008
2	Protein Isoforms (Isoforms)IBA 02/2009 - 03/2008
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2009 - 07/2008
2	Aldehyde DehydrogenaseIBA 08/2007 - 08/2005
2	Bile Acids and Salts (Bile Acids)IBA 05/2006 - 04/2005
2	Insulin-Like Growth Factor Binding Protein 3IBA 11/2002 - 08/2002
2	Insulin-Like Growth Factor I (IGF-1)IBA 11/2002 - 08/2002
1	Sitagliptin Phosphate (Januvia)FDA Link 04/2020
1	ApolipoproteinsIBA 04/2020
1	PlasmalogensIBA 03/2017
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	AminesIBA 01/2015
1	methyl 4-azidophenylacetimidate (APAI)IBA 01/2015
1	SugarsIBA 05/2014
1	Sucrose (Saccharose)IBA 05/2014
1	Protective AgentsIBA 01/2014
1	Epoxide HydrolasesIBA 08/2013
1	PolyphenolsIBA 05/2013
1	Estrogen ReceptorsIBA 02/2013
1	CytosineIBA 02/2013
1	Adenine FDA LinkGeneric 02/2013
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2013
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2013
1	Vitamin B 6IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2017 - 07/2010
2	Percutaneous Coronary Intervention 10/2004 - 11/2002
2	Stents 10/2004 - 05/2003
1	Oral Administration 03/2017